Form 4: Arvinas Insider Randy Teel Acquires Shares and Options Upon Appointment as Chief Business Officer
SEC Form 4 Filing
Randy Teel, Arvinas' Interim Chief Financial Officer, reports acquisition of shares and options related to his new role as Chief Business Officer.
Summary
- Randy Teel, an officer of Arvinas, Inc., filed a Form 4 on May 23, 2024, reporting transactions related to his role.
- On May 21, 2024, Teel acquired 13,300 shares of common stock and options to purchase 19,675 shares of common stock.
- These acquisitions are connected to his appointment as Chief Business Officer of Arvinas.
- The restricted stock units (RSUs) and options were granted under the company's 2018 Stock Incentive Plan.
- The RSUs and options will vest over two years, with half vesting on April 21, 2025, and the remainder on April 21, 2026.
- Following the reported transactions, Teel beneficially owns 59,341 shares of Arvinas common stock and options for 19,675 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The filing reflects standard executive compensation practices and insider ownership alignment, which are generally viewed favorably.
Positives
- The grant of RSUs and options to Randy Teel aligns his interests with those of the company and its shareholders.
- The vesting schedule encourages long-term commitment from Teel in his new role as Chief Business Officer.
Industry Context
This filing is a routine disclosure related to executive compensation and insider ownership, common in publicly traded companies. It reflects standard practices for incentivizing and aligning executive interests with shareholder value.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent.
- Vesting schedules of two years are fairly standard, aligning with typical performance evaluation cycles and encouraging long-term commitment.
- Companies like Amgen, Gilead, and Biogen also utilize similar equity-based compensation plans for their executives.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Business Officer | NA | Randy Teel | 05/21/2024 | Appointment as Chief Business Officer |
Stakeholder Impact
- Shareholders: The grant of equity to executives can align their interests with shareholder value.
- Employees: The appointment of a new Chief Business Officer can impact company strategy and operations.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: Grant of restricted stock units and stock options to Randy Teel. |
| 05/23/2024 | Date of Form 4 filing. |
| 04/21/2025 | First vesting date for half of the restricted stock units and stock options. |
| 04/21/2026 | Second vesting date for the remaining half of the restricted stock units and stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.